Detecting cognitive impairment in patients with Parkinson’s disease using a brief cognitive screening tool: Addenbrooke’s Cognitive Examination (ACE)
Fuente:
Redalyc
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artículo científico |
| Langue: | en |
| Publié: |
Associação Neurologia Cognitiva e do Comportamento
2008
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1876445161310912512 |
|---|---|
| author | Anabel Chade |
| author_facet | Anabel Chade |
| contents | Detecting cognitive impairment in patients with Parkinson’s disease using a brief cognitive screening tool: Addenbrooke’s Cognitive Examination (ACE) Anabel Chade María Roca Teresa Torralva Ezequiel Gleichgerrcht Nicolás Fabbro Gonzalo Gómez Arévalo Oscar Gershanik Facundo Manes Medicina screening tools Parkinson’s disease Alzheimer’s disease frontotemporal dementia Addenbrooke’s Cognitive Examination (ACE) Detecting cognitive impairment in patients with Parkinson’s disease is crucial for good clinical practice given the new therapeutic possibilities available. When full neuropsychological evaluations are not avail-able, screening tools capable of detecting cognitive difficulties become crucial. Objective: The goal of this study was to investigate whether the Spanish version of the Addenbrooke’s Cognitive Examination (ACE) is capable of detecting cognitive difficulties in patients with Parkinson’s disease and discriminating their cognitive profile from patients with dementia. Methods: 77 early dementia patients (53 with Alzheimer’s Disease and 24 with Frontotemporal Dementia), 22 patients with Parkinson’s disease, and 53 healthy controls were evaluated with the ACE. Results: Parkinson’s disease patients significantly differed from both healthy controls and dementia patients on ACE total score. Conclusions: This study shows that the Spanish version of the ACE is capable of detecting patients with cognitive impairment in Parkinson’s disease and is able to differentiate them from patients with dementia based on their general cognitive status. 2008 artículo científico 1980-5764 https://www.redalyc.org/articulo.oa?id=339529003010 en http://www.redalyc.org/revista.oa?id=3395 Dementia & Neuropsychologia application/pdf Associação Neurologia Cognitiva e do Comportamento Dementia & Neuropsychologia (Brasil) Num.3 Vol.2 |
| format | Artículo científico |
| id | redalyc_339529003010 |
| institution | Redalyc |
| language | en |
| publishDate | 2008 |
| publisher | Associação Neurologia Cognitiva e do Comportamento |
| spellingShingle | Detecting cognitive impairment in patients with Parkinson’s disease using a brief cognitive screening tool: Addenbrooke’s Cognitive Examination (ACE) Anabel Chade Medicina screening tools Parkinson’s disease Alzheimer’s disease frontotemporal dementia Addenbrooke’s Cognitive Examination (ACE) Detecting cognitive impairment in patients with Parkinson’s disease using a brief cognitive screening tool: Addenbrooke’s Cognitive Examination (ACE) Anabel Chade María Roca Teresa Torralva Ezequiel Gleichgerrcht Nicolás Fabbro Gonzalo Gómez Arévalo Oscar Gershanik Facundo Manes Medicina screening tools Parkinson’s disease Alzheimer’s disease frontotemporal dementia Addenbrooke’s Cognitive Examination (ACE) Detecting cognitive impairment in patients with Parkinson’s disease is crucial for good clinical practice given the new therapeutic possibilities available. When full neuropsychological evaluations are not avail-able, screening tools capable of detecting cognitive difficulties become crucial. Objective: The goal of this study was to investigate whether the Spanish version of the Addenbrooke’s Cognitive Examination (ACE) is capable of detecting cognitive difficulties in patients with Parkinson’s disease and discriminating their cognitive profile from patients with dementia. Methods: 77 early dementia patients (53 with Alzheimer’s Disease and 24 with Frontotemporal Dementia), 22 patients with Parkinson’s disease, and 53 healthy controls were evaluated with the ACE. Results: Parkinson’s disease patients significantly differed from both healthy controls and dementia patients on ACE total score. Conclusions: This study shows that the Spanish version of the ACE is capable of detecting patients with cognitive impairment in Parkinson’s disease and is able to differentiate them from patients with dementia based on their general cognitive status. 2008 artículo científico 1980-5764 https://www.redalyc.org/articulo.oa?id=339529003010 en http://www.redalyc.org/revista.oa?id=3395 Dementia & Neuropsychologia application/pdf Associação Neurologia Cognitiva e do Comportamento Dementia & Neuropsychologia (Brasil) Num.3 Vol.2 |
| title | Detecting cognitive impairment in patients with Parkinson’s disease using a brief cognitive screening tool: Addenbrooke’s Cognitive Examination (ACE) |
| topic | Medicina screening tools Parkinson’s disease Alzheimer’s disease frontotemporal dementia Addenbrooke’s Cognitive Examination (ACE) |
| url | https://www.redalyc.org/articulo.oa?id=339529003010 |